基本情報
- 標準SMILES
CCO[C@H]1O[C@@H]2OC3(C)CC[C@H]4[C@H](C)CC[C@@H]([C@H]1C)[C@@]24OO3- InChIKey
NLYNIRQVMRLPIQ-BVCZABNKSA-N- 分子式
- C17H28O5
- 平均分子量
- 312.4 g/mol
- 単同位体質量
- 312.19367399
名称と識別子
- 優先名称
- Dihydroartemisinin ethyl ether
- IUPAC
- (4S,5R,8S,9R,10S,12R,13R)-10-ethoxy-1,5,9-trimethyl-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadecane
- 現地名
- アルテモチル
- 英語名
- Arteether
- 分子式
- C17H28O5
- 分子量
- 312.4
名称と別名
名称をさらに表示
データベース識別子
- CAS
75887-54-6- PubChem CID
- 72416
- DTXSID
DTXSID6057821- ChEMBL
CHEMBL3560584
物性
構造計算による物性
- XLogP
- 3.4
- 極性表面積
- 46.2 Ų
- 水素結合供与体数
- 0
- 水素結合受容体数
- 5
- 回転可能結合数
- 2
- 重原子数
- 22
- 形式電荷
- 0
- 複雑度
- 443
物理化学的性質
- 融点
- 80 · 80-820C
- 比旋光度
- 21 · D21 +154.5° (c = 1.0 in CHCl3)
- 沸点
- 372.4 · 372.4±42.0 °C(Predicted)
- 比重(密度)
- 1.16 · 1.16±0.1 g/cm3(Predicted)
- 貯蔵温度
- 2 · Sealed in dry,2-8°C
- 溶解性
- クロロホルム(微量)、酢酸エチル(微量)
- 外見
- 個体
- 色
- 白い
- InChI
- InChI=1S/C17H28O5/c1-5-18-14-11(3)13-7-6-10(2)12-8-9-16(4)20-15(19-14)17(12,13)22-21-16/h10-15H,5-9H2,1-4H3/t10-,11-,12+,13+,14+,15-,16-,17-/m1/s1
- InChIKey
- NLYNIRQVMRLPIQ-XQLAAWPRSA-N
- SMILES
- O1[C@]23[C@@]4([H])O[C@@](C)(CC[C@@]2([H])[C@H](C)CC[C@@]3([H])[C@@H](C)[C@@H](OCC)O4)O1
- CAS データベース
- 75887 · 75887-54-6
化学的性質
化学的特性White Crystalline Solid
安全と法規制
安全データ
- wgk
- WGK 3
- Hazard Classifications
- Repr. 2
- ストレージクラス
- 13 - Non Combustible Solids
化学と産業
応用分野
説明Arteether reached the market in the Netherlands as a solution in sesame oil, administered by i.m. injection, for the treatment of severe malaria infections in children and adolescents. Artheether, a sesquiterpene acetal with an endoperoxide bridge, is an ether derivative of the naturally occuring compound artemisinin, the active component of Chinese herbal remedies. As the other structural analogs of artemisinin, such as artesunate or artemether, it acts rapidly against Plasmodium, the parasite responsible for the disease, during the early blood stage of its development. It also exhibits a gametocytocidal activity against Plasmodium falciparum, reducing its potential for transmission. Because the only controlled clinical studies had been performed in children and adolescents, this new antimalarial drug was only approved for young patients. Further studies in adults treated with 150 mg i.m. artemotil, once daily for three consecutive days, indicated that the drug was efficient, rapidly acting (parasite clearance time meanly 38 h) and well tolerated. A new promising achievement in the regression of malaria is the combination of artemisinin derivatives with other long-lived antimalarials as mefloquine or pyrimethamine/sulfa.
使用Derivative of Artemisinin. Antimalarial
上流・下流製品情報
上流原料
下流製品
サプライヤー50 社
関連反応
関連ノート
読み込み中…